查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422784

移植市场依产品（组织产品、免疫抑制药物、保存液）、应用（器官移植、组织移植）、最终用户（医院、移植中心等）及地区2024-2032

Transplantation Market by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End User (Hospitals, Transplantation Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球移植市场规模达160亿美元。展望未来， IMARC Group预计到2032年市场规模将达到336亿美元，2024-2032年复合年增长率（CAGR）为8.39%。由于医疗技术的快速进步、慢性病患病率的增加、政府和非政府组织(NGO) 推动器官捐赠的倡议不断增加、专业移植中心的扩张以及不断变化的医疗保健政策和保险覆盖范围，市场正在经历显着增长。

移植市场分析：

市场成长与规模：在技术快速进步、慢性病盛行率上升和医疗保健政策改善的推动下，市场正在稳定成长。

主要市场驱动因素：影响市场成长的主要驱动因素包括医疗技术的快速进步、慢性病导致的器官衰竭发病率上升、移植中心的扩张、政府的支持措施以及不断变化的医疗保健政策。

主要市场趋势：主要市场趋势涉及个人化移植医学的持续转变以及生物工程器官和组织的使用。此外，用于开发新免疫抑制药物和保存解决方案的研发（R&D）投资不断增加，也促进了市场成长。

地理趋势：北美因其先进的医疗保健系统、高移植率和强大的器官捐赠网路而引领市场。在医疗基础设施改善和消费者意识不断提高的推动下，其他地区也出现了显着增长。

竞争格局：市场的特征是主要参与者积极参与策略合併、收购和合作，专注于扩大产品组合和全球影响力。此外，公司也专注于投资研发（R&D），以在药物配方、组织工程和器官保存技术方面进行创新。

挑战与机会：市场面临各种挑战，例如管理器官捐赠者短缺、器官捐赠的伦理问题以及不同地区医疗保健取得的差异。然而，组织工程的进步和支持公平获得移植服务的政策的製定正在为市场成长创造新的机会。

移植市场趋势：

移植技术的快速进步

手术技术、免疫抑制药物和器官保存方面的不断进步和创新提高了移植成功率和患者预后，为市场成长创造了积极的前景。与此一致的是，微创（MI）手术方法的发展可减少恢復时间和併发症，从而提高器官移植的可行性和普及度，对市场成长有正面影响。此外，组织分型和匹配技术的快速进步将器官排斥的风险降至最低，正在促进市场成长。同时，数位和人工智慧 (AI) 技术在移植中的集成，可以实现更准确、更快速的器官匹配、预测患者结果和管理移植后护理，正在加强市场成长。

慢性病和器官衰竭的盛行率不断增加

糖尿病、高血压和心臟病等慢性病盛行率不断上升，导致器官移植需求增加，是推动市场成长的主要因素之一。与此一致的是，糖尿病和高血压导致的肾衰竭发生率不断上升，全球肾移植的需求不断增加，推动了市场的成长。同时，越来越多的心臟和肝臟疾病诊断，刺激了心臟和肝臟移植的需求，成为生长诱导因素。除此之外，容易患导致器官衰竭的慢性疾病的老年人口不断增加，也为市场创造了积极的前景。此外，对各种健康状况的认识提高和诊断改进，有助于及早识别需要移植的患者，正在促进市场成长。

政府和非政府组织（NGO）不断采取措施促进器官捐赠

政府和非政府组织（NGO）在促进器官捐赠方面的影响力日益增强，对市场成长产生了正面影响。与此一致的是，越来越多的宣传活动组织、简化的捐赠程序和支持性立法，导致器官捐赠者数量的增加，有利于市场的成长。除此之外，政府和非政府组织与医疗保健提供者为简化器官捐赠流程而迅速开展的合作正在刺激市场成长。同时，在捐赠过程中纳入家属同意的政策的出台以及国家捐赠登记处的建立正在促进市场的成长。此外，分享器官捐赠最佳实践和资源并加强全球移植网络的国际合作日益盛行，也支持了市场的成长。

扩大移植中心和服务

全球专业移植中心和服务的不断增长和扩张正在推动市场成长。专业移植中心配备了先进的设施和熟练的专业人员，能够执行复杂的移植手术。据此，专门中心的建立，确保更广泛地获得移植服务，满足不断增长的需要治疗的患者群体，正在推动市场成长。此外，这些中心更加重视专业移植和个人化护理，提供全面的护理，包括移植前咨询、先进的外科手术以及移植后随访和康復，这为市场成长提供了动力。此外，中心向农村和服务欠缺地区的扩张，使更广泛的人群更容易获得移植服务，正在促进市场成长。

不断扩大的医疗保健政策和保险覆盖范围

支持移植手术的各种政府医疗保健倡议的推出，包括资金、报销政策和保险范围，为市场成长提供了相当大的推动力。除此之外，各个医疗系统不断增加移植手术和成本标准化的努力也有利于市场的成长。除此之外，涵盖长期术后照护费用的医疗服务一体化，包括免疫抑制药物和定期监测排斥或併发症的迹象，正在促进市场成长。除此之外，随着政策制定者解决不同社会经济群体、种族和地区之间移植率的差异，人们越来越关注移植服务的公平性，也推动了市场的成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球移植市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 纸巾产品
    • 市场走向
    • 市场预测
  • 免疫抑制药物
    • 市场走向
    • 市场预测
  • 保存液
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 器官移植
    • 市场走向
    • 市场预测
  • 组织移植
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 移植中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 21st Century Medicine
    • AbbVie Inc.
    • Arthrex Inc.
    • Astellas Pharma Inc.
    • BioLife Solutions Inc.
    • CareDx Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • TransMedics Inc.
    • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
Product Code: SR112024A7197

Abstract

The global transplantation market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.39% during 2024-2032. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.

Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.

Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.

Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.

Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.

Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends:

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Tissue Products

Immunosuppressive Drugs

Preservation Solution

Tissue products account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes tissue products, immunosuppressive drugs, and preservation solution. According to the report, tissue products represented the largest segment.

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

Organ Transplantation

Tissue Transplantation

Tissue transplantation holds the largest share in the industry

A detailed breakup and analysis of the transplantation market based on the application has also been provided in the report. This includes organ transplantation and tissue transplantation. According to the report, tissue transplantation accounted for the largest market share.

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

Hospitals

Transplantation Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the transplantation market based on the end user. This includes hospitals, transplantation centers, and others. According to the report, hospitals represented the largest segment.

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

21st Century Medicine

AbbVie Inc.

Arthrex Inc.

Astellas Pharma Inc.

BioLife Solutions Inc.

CareDx Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

TransMedics Inc.

Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Latest News:

In January 2022, Novartis AG announced a collaboration with Alnylam for exploring targeted therapy to restore liver function with the help of Alnylam's siRNA.

In January 2022, BioLife Solutions extended its collaboration with Seattle Children 's Therapeutics to optimize and enhance biopreservation and closed-system manufacturing by integrating Sexton's AF-500 cell processing tools.

In December 2022, AbbVie Inc. announced its strategic partnership with HotSpot Therapeutics to develop its pipeline for immunology products.

Key Questions Answered in This Report

  • 1. How big is the global transplantation market?
  • 2. What is the expected growth rate of the global transplantation market during 2024-2032?
  • 3. What are the key factors driving the global transplantation market?
  • 4. What has been the impact of COVID-19 on the global transplantation market?
  • 5. What is the breakup of the global transplantation market based on the product?
  • 6. What is the breakup of the global transplantation market based on the application?
  • 7. What is the breakup of the global transplantation market based on the end user?
  • 8. What are the key regions in the global transplantation market?
  • 9. Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transplantation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Tissue Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressive Drugs
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Preservation Solution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Organ Transplantation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Transplantation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Transplantation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 21st Century Medicine
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Arthrex Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 BioLife Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 CareDx Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 TransMedics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Transplantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transplantation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transplantation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transplantation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Transplantation Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Transplantation Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Transplantation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Transplantation (Tissue Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Transplantation (Tissue Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transplantation (Immunosuppressive Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transplantation (Immunosuppressive Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transplantation (Preservation Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transplantation (Preservation Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transplantation (Organ Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transplantation (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transplantation (Tissue Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transplantation (Tissue Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transplantation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transplantation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transplantation (Transplantation Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transplantation (Transplantation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transplantation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transplantation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Transplantation Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Transplantation Industry: Drivers, Restraints, and Opportunities
  • Figure 74: Global: Transplantation Industry: Value Chain Analysis
  • Figure 75: Global: Transplantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transplantation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transplantation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Transplantation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Transplantation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Transplantation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Transplantation Market: Competitive Structure
  • Table 7: Global: Transplantation Market: Key Players